Australian Newspaper MSB trial failure, page-51

I’m all those, except listed. They can’t make decisions that favours a portion of shareholders. They have to make decisions based on what is best for the company and stakeholders as a whole. It is perfectly acceptable, and often the case, the long term decisions wins out over the short term. I actually like MSB because they don’t put out fluff ramps. No monthly newsletters for me, just facts, best guess and disclosures. There was enough new items that required an announcement. Most of the issues spoken about over the last two days are holders who want Novartis announced as committed, EUA announced or full approval. No matter how good the comms are, if these items haven’t happened, they haven’t happened. No fluff piece will change that. You could hire the best comms team in the world, and that won’t change anything that will satisfy those on here. I think people need to be careful what you wish for. Me I’m happy, there was some great information contained in the announcements. Unfortunately all we’ve had is a bunch of crybabies wanting it now. I think it’s great, I’ll just be able to buy more, at lower prices, and work with it. Bio’s take forever, you must have patience like a monk.